Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLO
2401
DELISTED
Olo Inc
OLO
| $207K | ﹤0.01% |
37,778
+31
| +0.1% | +$169 |
|
2402
SmartFinancial
SMBK
$906M
| $206K | ﹤0.01% |
9,798
-6,081
| -38% | -$134K |
|
2403
NETGEAR
NTGR
$612M
| $206K | ﹤0.01% |
13,089
+2
| +0% | +$29 |
|
2404
Medifast
MED
$107M
| $205K | ﹤0.01% |
5,360
-7,205
| -57% | -$349K |
|
2405
Washington Trust Bancorp
WASH
$748M
| $205K | ﹤0.01% |
7,648
+1
| +0% | +$27 |
|
2406
Castle Biosciences
CSTL
$742M
| $205K | ﹤0.01% |
9,266
-4
| -0% | -$87 |
|
2407
VTEX
VTEX
$767M
| $204K | ﹤0.01% |
25,053
| – | – |
|
2408
monday.com
MNDY
$3.82B
| $203K | ﹤0.01% |
+900
| New | +$191K |
|
|
VERV
2409
DELISTED
Verve Therapeutics
VERV
| $203K | ﹤0.01% |
15,287
+35
| +0.2% | +$464 |
|
|
BRY
2410
DELISTED
Berry Corp
BRY
| $202K | ﹤0.01% |
25,170
+3
| +0% | +$21 |
|
2411
United Fire Group
UFCS
$1.35B
| $202K | ﹤0.01% |
+9,281
| New | +$206K |
|
2412
First Financial Corp
THFF
$948M
| $202K | ﹤0.01% |
5,287
| – | – |
|
2413
Grid Dynamics Holdings
GDYN
$569M
| $202K | ﹤0.01% |
16,456
+2
| +0% | +$26 |
|
2414
Gogo Inc
GOGO
$525M
| $202K | ﹤0.01% |
23,008
+3
| +0% | +$27 |
|
2415
Bally's
BALY
$708M
| $201K | ﹤0.01% |
14,448
+1
| +0% | +$12 |
|
2416
Kearny Financial
KRNY
$604M
| $200K | ﹤0.01% |
31,243
+2
| +0% | +$14 |
|
2417
Green Dot
GDOT
$750M
| $200K | ﹤0.01% |
21,398
+3
| +0% | +$26 |
|
2418
SandRidge Energy
SD
$503M
| $199K | ﹤0.01% |
13,686
+2
| +0% | +$27 |
|
2419
Methode Electronics
MEI
$458M
| $199K | ﹤0.01% |
16,363
| – | – |
|
2420
Alignment Healthcare
ALHC
$3.78B
| $198K | ﹤0.01% |
39,994
-3
| -0% | -$19 |
|
2421
SI-BONE Inc
SIBN
$818M
| $197K | ﹤0.01% |
12,051
+2
| +0% | +$38 |
|
2422
Standard BioTools
LAB
$342M
| $196K | ﹤0.01% |
+72,061
| New | +$174K |
|
2423
Clean Energy Fuels
CLNE
$416M
| $195K | ﹤0.01% |
72,832
+8
| +0% | +$24 |
|
2424
Zymeworks
ZYME
$1.62B
| $195K | ﹤0.01% |
18,539
+3
| +0% | +$33 |
|
2425
BrightView Holdings
BV
$1.24B
| $194K | ﹤0.01% |
16,335
+1
| +0% | +$9 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.